Product Information
SULFAMETHOXAZOLE-TMP DS TABLET is a generic product labeled by Sun Pharmaceutical Industries Inc., priced at $0.0470 per EA under NDC 53489014601. Its NADAC has been published 639 times since Nov 28, 2013.
FDA first approved this application on Aug 25, 1986. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
800; 160 mg/1; mg/1
Manufacturer
Sun Pharmaceutical Industries Inc.NDC
53489014601
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
2/18/2026
Active Ingredients
SULFAMETHOXAZOLE; TRIMETHOPRIMApproval Type
Generic (ANDA)
FDA Application
ANDA071017FDA Approved
8/25/1986
TE Code
AB
On Market Since
8/25/1986
Pharmacological Classes
Price Statistics
The NADAC for SULFAMETHOXAZOLE-TMP DS TABLET has been published 639 times since Nov 28, 2013, and over the history we have for it it has declined 22.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0470 per EA |
|---|---|
| All-time high | $0.0980 (May 11, 2016) |
| All-time low | $0.0459 (Nov 20, 2024) |
| 52-week high | $0.0579 |
| 52-week low | $0.0470 |
| Median price | $0.0705 |
| Average price | $0.0697 |
| Largest weekly change | +30.3% (Aug 21, 2024) |
| Weeks tracked | 639 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
-18.8%
3Y
-16.0%
5Y
-27.8%
All
-22.4%
Last surveyed Feb 18, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 9 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 5% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Sun Pharmaceutical Industries Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Sulfamethoxazole and Trimethoprim market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Dihydrofolate Reductase Inhibitor Antibacterial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of SULFAMETHOXAZOLE-TMP DS TABLET?
The current National Average Drug Acquisition Cost (NADAC) for SULFAMETHOXAZOLE-TMP DS TABLET, manufactured by Sun Pharmaceutical Industries Inc., is $0.0470 per EA (NDC 53489014601), effective Feb 18, 2026.
How has the price of SULFAMETHOXAZOLE-TMP DS TABLET changed over time?
Over the history we have for it, the NADAC for SULFAMETHOXAZOLE-TMP DS TABLET has declined 22.4%. It has been tracked across 639 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for SULFAMETHOXAZOLE-TMP DS TABLET?
Since Nov 28, 2013, the NADAC for SULFAMETHOXAZOLE-TMP DS TABLET has ranged from a low of $0.0459 (Nov 20, 2024) to a high of $0.0980 (May 11, 2016), with a median of $0.0705 per EA.
Are there cheaper alternatives to SULFAMETHOXAZOLE-TMP DS TABLET?
Yes. 9 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, SULFAMETHOXAZOLE-TMP DS TABLET, is $0.0448 per EA — about 5% below SULFAMETHOXAZOLE-TMP DS TABLET.
Who manufactures SULFAMETHOXAZOLE-TMP DS TABLET?
SULFAMETHOXAZOLE-TMP DS TABLET (NDC 53489014601) is labeled by Sun Pharmaceutical Industries Inc., and CMS classifies it as a generic product.